EAACI Congress 2024
BackL-OAS 1 - Advances in Immunotherapy
Friday 31 May, 12:00 PM -
13:00 PM Valencia, Spain
Bilbao
Oral Abstract Sessions
12:00
Safety of subcutaneous immunotherapy with mixtures of two allergens at maximum concentration: 10 year real-world data
12:12
MRNA-delivered consensus allergens induce a neutralizing IgG response against food and pollen allergens
12:24
Long-term Follow-up After Peanut Oral Immunotherapy During Preschool Years: Lessons from the IMPACT Trial
12:36
Impact of a 3-tree sublingual immunotherapy liquid formulation in birch family pollen-allergic patients on prevention of disease progression and/or asthma onset
12:48
Purified free mannan promotes tolerogenic responses in peanut-stimulated human dendritic cells